CLINICAL_TRIALS trial_result · 2023-08-24

Clinical Trial Update: Early Treatment of Cytokine Storm Syndrome in Covid-19 [Phase 3]

Phase 3 trial of early treatment for cytokine storm in COVID-19 has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of Alabama at Birmingham | Conditions: Cytokine Storm, COVID-19 | Phase 3 | Status: COMPLETED | Results posted: 2023-08-24